Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
465 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Carcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
nasopharyngeal cancer | "Nasopharyngeal Carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Condition: Nasopharyngeal Carcinoma
Intervention:
2 Completed HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: interventional therapy
3 Active, not recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Intervention:
4 Recruiting Nasopharyngeal Carcinoma Screening in Zhongshan City
Condition: Nasopharyngeal Carcinoma
Intervention:
5 Not yet recruiting Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: Chemoradiotherapy for nasopharyngeal carcinoma
6 Recruiting Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis
Condition: Nasopharyngeal Carcinoma
Intervention:
7 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib
8 Unknown  Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Drug: Gemcitabine and cisplatin;   Drug: Cisplatin
9 Active, not recruiting Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Capecitabine;   Drug: Adjuvant chemotherapy using PF (5-Fluorouracil );   Drug: Induction chemotherapy using PF (5-Fluorouracil)
10 Unknown  Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Icotinib;   Radiation: intensity-modulated radiotherapy;   Drug: Paclitaxel and Cisplatin;   Other: Quality of life;   Genetic: Epidermal growth factor receptor status
11 Recruiting TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Other: Drug: Taxol,cisplatin and capecitabine;   Other: Drug: Cisplatin and 5-Fluorouracil
12 Recruiting The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: cisplatin;   Radiation: Intensity-modulated Radiotherapy
13 Completed Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil (5-FU)
14 Terminated SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: S-1 plus oxaliplatin
15 Completed Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Biological: DNAzyme targeting EBV-LMP1 (DZ1);   Other: Saline
16 Active, not recruiting Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Proton/Photon Radiotherapy;   Drug: Cisplatin;   Drug: Fluorouracil
17 Recruiting The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Celecoxib;   Drug: Nedaplatin;   Radiation: Concurrent Radiotherapy
18 Unknown  Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: endostatin
19 Not yet recruiting Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: Sodium nitrate;   Dietary Supplement: sodium chloride
20 Active, not recruiting Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.
Condition: Nasopharyngeal Carcinoma
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.